Philippines To Set National R&D Priorities, But Regulations May Hamper Foreign Industry Support
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The Philippines government is formulating research priorities for the next five years, including health and biotechnology projects, to boost the country's research and development capabilities. But some industry observers warn that the country's desire to maintain drug prices through the use of steep price cuts will discourage foreign companies from participating in the country's life sciences development